Jerome Burnet

1.1k total citations
14 papers, 597 citations indexed

About

Jerome Burnet is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jerome Burnet has authored 14 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jerome Burnet's work include Virus-based gene therapy research (6 papers), Cancer Research and Treatments (3 papers) and RNA Interference and Gene Delivery (3 papers). Jerome Burnet is often cited by papers focused on Virus-based gene therapy research (6 papers), Cancer Research and Treatments (3 papers) and RNA Interference and Gene Delivery (3 papers). Jerome Burnet collaborates with scholars based in United Kingdom, Spain and France. Jerome Burnet's co-authors include Julie Foster, Pilar Martín‐Duque, Stephen J. Mather, Miguel Quintanilla, John Maher, David M. Davies, Georges Vassaux, Scott Wilkie, Ana C. Parente‐Pereira and Jane Sosabowski and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Jerome Burnet

14 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerome Burnet United Kingdom	12	275	200	183	124	98	14	597
Pranay D. Khare United States	10	408 1.5×	193 1.0×	188 1.0×	197 1.6×	139 1.4×	17	701
Anton Neschadim Canada	16	146 0.5×	253 1.3×	160 0.9×	182 1.5×	38 0.4×	27	629
Caroline Arber United States	16	504 1.8×	235 1.2×	164 0.9×	343 2.8×	132 1.3×	30	762
Huajun Jin China	15	414 1.5×	321 1.6×	171 0.9×	238 1.9×	93 0.9×	27	731
Matthew Tiffany United States	10	241 0.9×	327 1.6×	152 0.8×	244 2.0×	100 1.0×	15	678
Narendiran Rajasekaran United States	12	170 0.6×	154 0.8×	78 0.4×	233 1.9×	32 0.3×	40	531
P. Markus Deckert Germany	16	256 0.9×	323 1.6×	77 0.4×	127 1.0×	29 0.3×	44	838
Kathy Mulgrew United States	11	557 2.0×	412 2.1×	268 1.5×	280 2.3×	51 0.5×	24	980
Jin He China	10	107 0.4×	236 1.2×	105 0.6×	281 2.3×	47 0.5×	25	676
Xuexiang Du United States	10	586 2.1×	204 1.0×	96 0.5×	504 4.1×	61 0.6×	21	856

Countries citing papers authored by Jerome Burnet

Since Specialization

Citations

This map shows the geographic impact of Jerome Burnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome Burnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome Burnet more than expected).

Fields of papers citing papers by Jerome Burnet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome Burnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome Burnet. The network helps show where Jerome Burnet may publish in the future.

Co-authorship network of co-authors of Jerome Burnet

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome Burnet. A scholar is included among the top collaborators of Jerome Burnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome Burnet. Jerome Burnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Vassaux, Georges, Jerome Burnet, Miguel Quintanilla, et al.. (2022). Mesenchymal Stem Cells Delivery in Individuals with Different Pathologies: Multimodal Tracking, Safety and Future Applications. International Journal of Molecular Sciences. 23(3). 1682–1682. 9 indexed citations

Pham, Binh T. T., Jerome Burnet, Ruslan Garipov, et al.. (2021). Performance evaluation of a PET insert for preclinical MRI in stand-alone PET and simultaneous PET–MRI modes. EJNMMI Physics. 8(1). 68–68. 6 indexed citations

Laverman, Peter, Lieke Joosten, Maggie Cooper, et al.. (2014). PET and SPECT Imaging of a Radiolabeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with ⁶⁴Cu, ⁶⁸Ga, and ¹¹¹In. Molecular Pharmaceutics. 11(11). 3930–3937. 62 indexed citations

Foster, Julie, Ciara Finucane, Chantelle Hudson, et al.. (2014). Evaluation and comparison of a new DOTA and DTPA - bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models. Applied Radiation and Isotopes. 96. 91–101. 13 indexed citations

Mendoza, Gracia, Daniel Öberg, Jerome Burnet, et al.. (2013). Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivoeffects on migration capacity and tumor growth. BMC Medicine. 11(1). 139–139. 64 indexed citations

Kogelberg, Heide, Enrique Miranda, Jerome Burnet, et al.. (2013). Generation and Characterization of a Diabody Targeting the αvβ6 Integrin. PLoS ONE. 8(9). e73260–e73260. 12 indexed citations

Sosabowski, Jane, Armin Sepp, Marie Davies, et al.. (2013). Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies. PLoS ONE. 8(2). e57263–e57263. 17 indexed citations

Stegen, Sjoukje J. C. van der, David M. Davies, Scott Wilkie, et al.. (2013). Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?. The Journal of Immunology. 191(9). 4589–4598. 100 indexed citations

Parente‐Pereira, Ana C., Jerome Burnet, David H. Ellison, et al.. (2011). Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice. Journal of Clinical Immunology. 31(4). 710–718. 87 indexed citations

10.

Chisholm, Edward J., Georges Vassaux, Pilar Martín‐Duque, et al.. (2009). Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles. Cancer Research. 69(6). 2655–2662. 55 indexed citations

11.

Baril, Patrick, Sophie Conchon, Pilar Martín‐Duque, et al.. (2009). Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter. Clinical Cancer Research. 15(21). 6595–6601. 53 indexed citations

12.

Martín‐Duque, Pilar, Antonio De la Vieja, Miguel Quintanilla, et al.. (2008). Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer. Cancer Gene Therapy. 15(7). 465–473. 14 indexed citations

13.

Martín‐Duque, Pilar, Jerome Burnet, Miguel Quintanilla, et al.. (2007). SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene Therapy. 14(24). 1731–1738. 59 indexed citations

14.

Tuthill, Tobias J., Nikolaos G. Papadopoulos, Patrick Jourdan, et al.. (2003). Mouse respiratory epithelial cells support efficient replication of human rhinovirus. Journal of General Virology. 84(10). 2829–2836. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact